[PubMed] [Google Scholar] 16
[PubMed] [Google Scholar] 16. from severe disease but is limited by its expense (1). The development of fresh therapeutic providers and vaccine methods holds the promise of reducing morbidity and mortality from this important pathogen (14). The part of prostanoids in modulating RSV illness in vivo is definitely unknown. Recent reports suggest that prostaglandin I2…